Phase 2 Trial of TD 6424 Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections

This study has been completed.

Study NCT00061633 Information provided by Theravance

First Received: May 30, 2003 Last Updated: June 23, 2005 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	December 2003
Estimated Primary Completion Date:	No date given